Found 102 matching trials
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. PHASE2 This is a multicenter, two-arm, exploratory clinical study designed to eval...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients PHASE3 Breast cancer is the most common malignant tumor in women. Recurrent or met...
Show More Learn More & Join Trial
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy PHASE2 This study is being conducted in patients with newly diagnosed breast cance...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP] PHASE2 A phase 2 open-label, randomized, multi-center trial to evaluate the effica...
Show More Status
Active Not Recruiting
Location
Cedars Sinai Medical Center
Learn More & Join Trial
A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer PHASE2 This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Show More Location
Multiple Locations
Learn More & Join Trial
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial PHASE2 VALENTINE is a parallel, non-comparative, three-arm, randomized 1:2:2 open-...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer PHASE2 The purpose of this clinical trial is to evaluate the efficacy and safety o...
Show More Learn More & Join Trial
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer PHASE2 The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Show More Location
Skåne University Hospital
Learn More & Join Trial
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery PHASE2 This phase II trial studies how well TPIV100 and sargramostim work in treat...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Step Count and Treatment Response in Neoadjuvant Breast Cancer N/A This prospective multicenter observational study (NEOBRE-STEP) investigates...
Show More Location
Etlik City Hospital, Medical Oncology Department
Learn More & Join Trial